Prestige Consumer Healthcare (PBH) Return on Capital Employed Growth (1y) (2012 - 2025)
Prestige Consumer Healthcare (PBH) Return on Capital Employed Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -494.00 |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 89.00 |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 448.00 |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 1,397.00 |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -1,715.00 |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 999.00 |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -2,309.00 |
| 10 | Prestige Consumer Healthcare | 2.39 Bn | 2.33 Bn | 157.37 Mn | -58.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -58.00 |
| Sep 30, 2025 | -10.00 |
| Jun 30, 2025 | -12.00 |
| Mar 31, 2025 | -33.00 |
| Dec 31, 2024 | 1,091.00 |
| Sep 30, 2024 | 1,079.00 |
| Jun 30, 2024 | 1,105.00 |
| Mar 31, 2024 | 1,132.00 |
| Dec 31, 2023 | -1,010.00 |
| Sep 30, 2023 | -1,003.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,003.00 |
| Dec 31, 2022 | 30.00 |
| Sep 30, 2022 | 33.00 |
| Jun 30, 2022 | 9.00 |
| Mar 31, 2022 | 43.00 |
| Dec 31, 2021 | 12.00 |
| Sep 30, 2021 | -11.00 |
| Jun 30, 2021 | 21.00 |
| Mar 31, 2021 | 22.00 |